Sugi Predict

Sugi Predict / Compounds / SCHEMBL17023889

SCHEMBL17023889

SCHEMBL17023889

CCn1c(-c2nc(-c3ncccn3)n3ccccc23)ccc1-c1nc(-c2ncccn2)n2ccccc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.38
▸ MEN1 O00255 4/20 0.36
▸ KMT2A Q03164 4/20 0.36
▸ GAA P10253 2/20 0.36
▸ POLB P06746 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ HIF1A Q16665 9/20 0.36
▸ EPAS1 Q99814 9/20 0.36
▸ KDM4E B2RXH2 4/20 0.36
▸ MAPT P10636 3/20 0.36
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17037039 0.87 ALDH1A1 (0.43) ALDH1A1MEN1KMT2AGAAHPGD
SCHEMBL17023880 0.83 MEN1 (0.47) ALDH1A1MEN1KMT2AGAAPOLB
SCHEMBL17023875 0.80 KMT2A (0.40) ALDH1A1MEN1KMT2AGAAPOLB
SCHEMBL17023884 0.79 GAA (0.43) ALDH1A1MEN1KMT2AGAAPOLB
SCHEMBL17023900 0.78 KMT2A (0.52) ALDH1A1MEN1KMT2AGAAPOLB
SCHEMBL17023876 0.77 KMT2A (0.48) ALDH1A1MEN1KMT2AGAAPOLB
SCHEMBL17023902 0.76 GAA (0.40) ALDH1A1MEN1KMT2AGAAPOLB
SCHEMBL17023882 0.74 HIF1A (0.47) MEN1KMT2AGAAPOLBHPGD
SCHEMBL17023892 0.74 KMT2A (0.49) ALDH1A1MEN1KMT2AGAAPOLB
SCHEMBL17023873 0.70 KMT2A (0.42) ALDH1A1MEN1KMT2AGAAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10847726-B2 Imidizo derivatives THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 2020-11-24 — — US disclosed
US-10847726-B2 Imidizo derivatives THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 2020-11-24 — — US disclosed
US-20190131538-A1 IMIDIZO DERIVATIVES THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY 2019-05-02 — — US disclosed
US-20190131538-A1 IMIDIZO DERIVATIVES THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY 2019-05-02 — — US disclosed
US-20150243896-A1 IMIDAZO DERIVATIVES ARMY, THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE 2015-08-27 — — US disclosed
US-20150243896-A1 IMIDAZO DERIVATIVES ARMY, THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE 2015-08-27 — — US disclosed
US-20150243896-A1 IMIDAZO DERIVATIVES ARMY, THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE 2015-08-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190131538-A1 IMIDIZO DERIVATIVES IKZF1, IKZF3, IKZF2 ALDH1A1 1401/4885MEN1 3752/4885KMT2A 1089/4885
US-10847726-B2 Imidizo derivatives IKZF1, IKZF3, IKZF2 ALDH1A1 1401/4885MEN1 3752/4885KMT2A 1089/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.